Article

FDA clears use of Opti-Free replenish with SynergEyes contact lenses

Carlsbad, CA-SynergEyes Inc. has received FDA market clearance for the use of Alcon Opti-Free Replenish multi-purpose disinfecting solution with SynergEyes contact lenses.

Carlsbad, CA-SynergEyes Inc. has received FDA market clearance for the use of Alcon Opti-Free Replenish multi-purpose disinfecting solution with SynergEyes contact lenses.

According to SynergEyes co-founder and Chief Technology Officer Jerry Legerton, OD, FAAO, "Opti-Free Replenish proved to be compatible with our HydrolEyes surface science and complements our materials on eye. The care product requirements for the combination of hydrophilic and hydrophobic surface groups in our hybrid lens are similar to the requirements for silicone hydrogel lenses."

SynergEyes manufactures a new type of contact lens that combines two materials, a rigid gas permeable center and a soft, hydrophilic outer skirt. The result is a durable "hybrid" lens for patients seeking crisp, clear vision and the all-day comfort of a soft lens.

Related Videos
(Image credit: Ophthalmology Times) AGS 2025: Constance Okeke, MD, highlights 1-year Streamline canaloplasty outcomes
(Image credit: Ophthalmology Times) AGS 2025: Two-year data of bio-interventional cyclodialysis with scleral allograft with Leon W. Herndon Jr, MD
(Image credit: Ophthalmology Times) AGS 2025: Aqueous humor outflow improvement after excimer laser trabeculostomy with Clemens Strohmaier, PhD
(Image credit: Ophthalmology Times) Thomas W. Samuelson, MD, shares clinical perspectives on DSLT, SLT, and glaucoma management
Image credit: Ophthalmology Times; Dean McGee Eye Institute resident Ashley Ooms, MD, explores gray area strabismus surgery complications in AUPO poster
Image credit: Ophthalmology Times; EnVision Summit 2025: Sonia H. Yoo, MD, shares what to expect from the cataract and refractive agenda
Image credit: ©Ophthalmology Times
Wendy Lee, MD, talks about functional oculoplastics and aesthetics at EnVision Summit 2025
© 2025 MJH Life Sciences

All rights reserved.